✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Emcure Pharmaceuticals Ltd.

EMCURE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹25,850 Cr.
P/E
37.94

Emcure Pharmaceuticals Ltd.

  • Emcure Pharma
  • Wockhardt
  • Piramal Pharma
FAQs on Emcure Pharmaceuticals Ltd. Shareprice

Emcure Pharma has given lower returns compared to its competitors.
Emcure Pharma has grown at ~3.49% over the last 1yrs while peers have grown at a median rate of 18.0%

Yes, Emcure Pharma is expensive.
Latest PE of Emcure Pharma is 84.15, while 3 year average PE is 46.85.
Also latest EV/EBITDA of Emcure Pharma is 18.49 while 3yr average is 18.22.

View FAQ's On Business
Growth Table
  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • Piramal Pharma
Balance Sheet
  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • Piramal Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • Piramal Pharma
Cash Flow
  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • Piramal Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • Piramal Pharma
Quarterly Results
  • Emcure Pharmaceuticals Ltd.
  • Wockhardt
  • Piramal Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Emcure Pharmaceuticals Ltd. Financials

Balance sheet of Emcure Pharma is strong.
But short term working capital might become an issue for this company.

The net debt of Emcure Pharma is decreasing.
Latest net debt of Emcure Pharma is ₹566 Crs as of Mar-25.
This is less than Mar-24 when it was ₹1,608 Crs.

The profit is oscillating.
The profit of Emcure Pharma is ₹707 Crs for TTM, ₹498 Crs for Mar 2024 and ₹532 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Emcure Pharma latest dividend payout ratio is 10.91% and 3yr average dividend payout ratio is 8.63%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech